Weller M - Search Results

1

Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities.

Reuss DE, Kratz A, Sahm F, Capper D, Schrimpf D, Koelsche C, Hovestadt V, Bewerunge-Hudler M, Jones DT, Schittenhelm J, Mittelbronn M, Rushing E, Simon M, Westphal M, Unterberg A, Platten M, Paulus W, Reifenberger G, Tonn JC, Aldape K, Pfister SM, Korshunov A, Weller M, Herold-Mende C, Wick W, Brandner S, von Deimling A. Reuss DE, et al. Among authors: weller m. Acta Neuropathol. 2015 Sep;130(3):407-17. doi: 10.1007/s00401-015-1454-8. Epub 2015 Jun 19. Acta Neuropathol. 2015. PMID: 26087904 Free article.

2

BCL-2 promotes migration and invasiveness of human glioma cells.

Wick W, Wagner S, Kerkau S, Dichgans J, Tonn JC, Weller M. Wick W, et al. Among authors: weller m. FEBS Lett. 1998 Dec 4;440(3):419-24. doi: 10.1016/s0014-5793(98)01494-x. FEBS Lett. 1998. PMID: 9872414 Free article.

3

Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth.

Ständer M, Naumann U, Wick W, Weller M. Ständer M, et al. Among authors: weller m. Cell Tissue Res. 1999 May;296(2):221-7. doi: 10.1007/s004410051283. Cell Tissue Res. 1999. PMID: 10382266 Review.

4

Patterns of cyclooxygenase-1 and -2 expression in human gliomas in vivo.

Deininger MH, Weller M, Streffer J, Mittelbronn M, Meyermann R. Deininger MH, et al. Among authors: weller m. Acta Neuropathol. 1999 Sep;98(3):240-4. doi: 10.1007/s004010051075. Acta Neuropathol. 1999. PMID: 10483780

5

Transforming growth factors beta(1) (TGF-beta(1)) and TGF-beta(2) promote glioma cell migration via Up-regulation of alpha(V)beta(3) integrin expression.

Platten M, Wick W, Wild-Bode C, Aulwurm S, Dichgans J, Weller M. Platten M, et al. Among authors: weller m. Biochem Biophys Res Commun. 2000 Feb 16;268(2):607-11. doi: 10.1006/bbrc.2000.2176. Biochem Biophys Res Commun. 2000. PMID: 10679251

6

Role of TGF-beta in oncogenesis.

Weller M, Wick W, Platten M. Weller M, et al. Microsc Res Tech. 2001 Feb 15;52(4):353. doi: 10.1002/1097-0029(20010215)52:4<353::AID-JEMT1019>3.0.CO;2-U. Microsc Res Tech. 2001. PMID: 11170293 No abstract available.

7

Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape.

Platten M, Wick W, Weller M. Platten M, et al. Among authors: weller m. Microsc Res Tech. 2001 Feb 15;52(4):401-10. doi: 10.1002/1097-0029(20010215)52:4<401::AID-JEMT1025>3.0.CO;2-C. Microsc Res Tech. 2001. PMID: 11170299 Review.

8

Treosulfan chemotherapy for recurrent malignant glioma.

Schmidt F, Wick W, Herrlinger U, Dichgans J, Weller M. Schmidt F, et al. Among authors: weller m. J Neurooncol. 2000 Sep;49(3):231-4. doi: 10.1023/a:1006496831144. J Neurooncol. 2000. PMID: 11212902 Clinical Trial.

9

Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma.

Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W. Wild-Bode C, et al. Among authors: weller m. Cancer Res. 2001 Mar 15;61(6):2744-50. Cancer Res. 2001. PMID: 11289157

10

Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis.

Roth W, Isenmann S, Nakamura M, Platten M, Wick W, Kleihues P, Bähr M, Ohgaki H, Ashkenazi A, Weller M. Roth W, et al. Among authors: weller m. Cancer Res. 2001 Mar 15;61(6):2759-65. Cancer Res. 2001. PMID: 11289159

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,705 results

Search Page

Filters